61026 Federal Register / Vol. 69, No. 198 / Thursday, October 14, 2004 / Notices 

ACTION: General notice.

SUMMARY: Health Resources and 

Services Administration (HRSA) 

announces the availability of funds in 

the fiscal year (FY) 2005 HRSA Preview. 

The HRSA Preview is a comprehensive 

review of HRSA’s fiscal year 2005 

competitive programs. The purpose of 

the HRSA Preview is to provide the 

general public with a single source of 

program and application information 

related to the Agency’s competitive 

grant offerings. The HRSA Preview is 

designed to replace the multiple Federal 

Register notices that traditionally 

advertised the availability of HRSA’s 

discretionary funds for its various 

programs. A printer-friendly copy of the 

Preview can be downloaded at http://

www.hrsa.gov/grants/preview/

default.htm. A hard copy can be 

requested by contacting the HRSA 

Information Center at: HRSA 

Information Center, 2710 Prosperity 

Avenue, Fairfax, VA 22031, Telephone: 

1–800–ASK–HRSA, http://

www.hrsa.gov.

It should be noted that additional 

program initiatives responsive to new or 

emerging issues in the health care area 

and unanticipated at the time of 

publication of the HRSA Preview may 

be announced through the Federal 

Register and the HRSA Web site http:/

/www.hrsa.gov/grants.htm. A list of 

these programs can also be found at the 

Grants.gov Web site: http://

www.grants.gov.

HRSA continues to accept grant 

applications online. Please refer to the 

HRSA Web site at http://www.hrsa.gov/

grants/preview/default.htm for more 

information.

Dated: October 6, 2004. 

Elizabeth M. Duke, 

Administrator.

[FR Doc. 04–23107 Filed 10–13–04; 8:45 am] 

BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Notice of Meeting of the Advisory 

Committee on Organ Transplantation

AGENCY: Health Resources and Services 

Administration, HHS.

SUMMARY: Pursuant to Public Law 92–

463, the Federal Advisory Committee 

Act, as amended (5 U.S.C. Appendix 2), 

notice is hereby given of the seventh 

meeting of the Advisory Committee on 

Organ Transplantation (ACOT), 

Department of Health and Human 

Services (HHS). The meeting will be 

held from approximately 9 a.m. to 5:30 

p.m. on November 4, 2004, and from 9 

a.m. to 5 p.m. on November 5, 2004, at 

the Rockville DoubleTree Hotel, 1750 

Rockville Pike, Rockville, MD 20852. 

The meeting will be open to the public; 

however, seating is limited and preregistration is encouraged (see below).

SUPPLEMENTARY INFORMATION: Under the 

authority of 42 U.S.C. 217a, Section 222 

of the Public Health Service Act, as 

amended, and 42 CFR 121.12 (2000), 

ACOT was established to assist the 

Secretary in enhancing organ donation, 

ensuring that the system of organ 

transplantation is grounded in the best 

available medical science, and assuring 

the public that the system is as effective 

and equitable as possible, and, thereby, 

increasing public confidence in the 

integrity and effectiveness of the 

transplantation system. ACOT is 

composed of up to 25 members, 

including the Chair. Members are 

serving as Special Government 

Employees and have diverse 

backgrounds in fields such as organ 

donation, health care public policy, 

transplantation medicine and surgery, 

critical care medicine and other medical 

specialties involved in the identification 

and referral of donors, non-physician 

transplant professions, nursing, 

epidemiology, immunology, law and 

bioethics, behavioral sciences, 

economics and statistics, as well as 

representatives of transplant candidates, 

transplant recipients, organ donors, and 

family members. 

ACOT will hear and discuss reports 

from the following ACOT 

subcommittees: Valuable Consideration 

Subcommittee, Fair Treatment 

Subcommittee, and Wait List 

Subcommittee. 

The draft meeting agenda will be 

available on October 18 on the 

Department’s donation Web site at http:/

/www.organdonor.gov/acot.html.

A registration form will be available 

on October 4 on the Department’s 

donation Web site at http://

www.organdonor.gov/acot.html. The 

completed registration form should be 

submitted by facsimile to Professional 

and Scientific Associates (PSA), the 

logistical support contractor for the 

meeting, at fax number (703) 234–1701. 

Individuals without access to the 

Internet who wish to register may call 

Bryan Slattery with PSA at (703) 234–

1734. Individuals who plan to attend 

the meeting and need special assistance, 

such as sign language interpretation or 

other reasonable accommodations, 

should notify the ACOT Executive 

Director, Thomas E. Balbier, Jr., in 

advance of the meeting. Mr. Balbier may 

be reached by telephone at 301–443–

1896, e-mail: tbalbier@hrsa.gov, or in 

writing at the address of the Division of 

Transplantation provided below. 

Management and support services for 

ACOT functions are provided by the 

Division of Transplantation, Healthcare 

Systems Bureau, Health Resources and 

Services Administration, 5600 Fishers 

Lane, Parklawn Building, Room 12C–04, 

Rockville, Maryland 20857; telephone 

number 301–443–7577. 

After the presentation of the 

subcommittee reports, members of the 

public will have an opportunity to 

provide comments on the subcommittee 

reports. Because of the Committee’s full 

agenda and the timeframe in which to 

cover the agenda topics, public 

comment will be limited. All public 

comments will be included in the 

record of the ACOT meeting.

Dated: October 6, 2004. 

Elizabeth M. Duke, 

Administrator.

[FR Doc. 04–23108 Filed 10–13–04; 8:45 am] 

BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of The Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Director’s Council of Public 

Representatives. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting.

Name of Committee: Director’s Council of 

Public Representatives. 

Date: October 27, 2004. 

Time: 3 p.m. to 5 p.m. 

Agenda: The COPR will present 

information and findings from a workshop 

that will meet on October 26, 2004. The 

workshop is part of a larger 80 percent 

workshop that the COPR is hosting in 

collaboration with the NIH Public Trust 

initiative. Additional agenda items include: 

(1) Welcoming remarks by the NIH Director; 

(2) discussion and public comment; and (3) 

the NIH Director’s initial response and 

comments. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892. 

Federal Register / Vol. 69, No. 198 / Thursday, October 14, 2004 / Notices 61027

Contact Person: Jennifer E. Gorman Vetter, 

NIH Public Liaison/COPR Coordinator, Office 

of Communications and Public Liaison, 

Office of the Director, National Institutes of 

Health, 9000 Rockville Pike, Building 1, 

Room 344, Bethesda, MD 20892, (301) 435–

4448, gormanj@od.nih.gov.

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by non-government 

employees. Persons without a government 

I.D. will need to show a photo I.D. and signin at the security desk upon entering the 

building. 

Information is also available on the 

Institute’s/Center’s home page: www.nih.gov/

about/publicliaison/index.html, where an 

agenda and any additional information for 

the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS)

Dated: October 6, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–22989 Filed 10–13–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Cancer Institute Board of 

Scientific Advisors. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting.

Name of Committee: National Cancer 

Institute Board of Scientific Advisors. 

Date: November 8–9, 2004. 

Time: November 8, 2004, 8 a.m. to 6 p.m. 

Agenda: Director’s Report; Ongoing and 

New Business; Reports of Program Review 

Group(s); and Budget Presentation; Reports of 

Special Initiatives; RFA and RFP Concept 

Reviews; and Scientific Presentations. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Time: November 9, 2004, 8:30 a.m. to 1 

p.m. 

Agenda: Reports of Special Initiatives; RFA 

and RFP Concept Reviews; and Scientific 

Presentations. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Contact Person: Paulette S. Gray, PhD, 

Executive Secretary, Acting Director, 

Division of Extramural Activities, National 

Cancer Institute, National Institutes of 

Health, 6116 Executive Boulevard, 8th Floor, 

Rm. 8001, Bethesda, MD 20892, 301–496–

5147. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/bsa.htm, where 

an agenda and any additional information for 

the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS)

Dated: October 6, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–22991 Filed 10–13–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Cancer Institute Director’s 

Consumer Liaison Group. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting.

Name of Committee: National Cancer 

Institute Director’s Consumer Liaison Group. 

Date: November 4, 2004. 

Time: 3 p.m. to 4:45 p.m. 

Agenda: Report from NCI Listens and 

Learns Operations Working Group/

Discussion; Report from NCI Listens and 

Learns Promotions Working Group/

Discussion; Report from NCI Listens and 

Learns Summit Working Group/Discussion; 

Report from NCI Listens and Learns 

Evaluation Working Group/Discussion; Next 

Steps. 

Place: National Institutes of Health, 

National Cancer Institute, 6116 Executive 

Boulevard, Suite 220, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Nancy Caliman, Executive 

Secretary, Office of Liaison Activities, 

National Institutes of Health, National Cancer 

Institute, 6116 Executive Boulevard, Suite 

220, MSC8324, Bethesda, MD 20892, (301) 

496–0307, calimann@mail.nih.gov.

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/dclg/dclg.htm,

where an agenda and any additional 

information for the meeting will be posted 

when available.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support, 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS)